
Opioid-use disorders are common, but most physicians are not trained to recognize and treat them. This review outlines a general approach to identifying and treating these disorders.
Biomedical and clinical sciences, Opioid, Neurodegenerative, Medical and Health Sciences, Substance Misuse, General & Internal Medicine, Opiate Substitution Treatment, Humans, Analgesics, Biomedical and Clinical Sciences, Mental Disorders, Neurosciences, Health sciences, Pharmacology and Pharmaceutical Sciences, Opioid-Related Disorders, Brain Disorders, Buprenorphine, Substance Withdrawal Syndrome, Analgesics, Opioid, Mental health, Drug Abuse (NIDA only), Adrenergic alpha-Agonists, Methadone
Biomedical and clinical sciences, Opioid, Neurodegenerative, Medical and Health Sciences, Substance Misuse, General & Internal Medicine, Opiate Substitution Treatment, Humans, Analgesics, Biomedical and Clinical Sciences, Mental Disorders, Neurosciences, Health sciences, Pharmacology and Pharmaceutical Sciences, Opioid-Related Disorders, Brain Disorders, Buprenorphine, Substance Withdrawal Syndrome, Analgesics, Opioid, Mental health, Drug Abuse (NIDA only), Adrenergic alpha-Agonists, Methadone
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 429 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
